Cases of a highly contagious Victorian disease are on the rise in the UK, with experts attributing the increase to a lack of awareness about the condition. Top dermatologists have expressed concerns that misinformation is leading people to overlook the disease. Data from General Practitioners (GPs) show that nearly 900 cases of scabies have been reported in England, marking a nearly 20% jump compared to the previous year.
The UK Health Security Agency has observed a consistent yearly rise in scabies cases between 2021 and 2025, with a notable surge since 2023. Professor Tess McPherson, an associate professor specializing in pediatric health and adolescent dermatology at the University of Oxford, highlighted the prevalence of misinformation surrounding scabies, emphasizing that it spreads through skin-to-skin contact.
Scabies transmission is most common among individuals in close proximity, such as those in shared housing or sports teams. Professor McPherson pointed out that people residing in group facilities like university halls or care homes are particularly vulnerable. Factors contributing to the spike in cases include delays in diagnosis and treatment initiation, as well as the stigma associated with the disease, which may deter individuals from seeking help promptly.
The disease manifests as an itchy rash caused by microscopic mites that burrow into the skin to reproduce. These mites, measuring around 0.4mm in diameter, are invisible to the naked eye but can burrow up to 2.5cm beneath the skin. Scabies mites can survive outside the body for up to 36 hours, and a small number of female mites can trigger a significant outbreak. However, scabies is often misdiagnosed, with many mistaking it for common winter skin issues due to weather changes.
Early detection and treatment are crucial to managing scabies effectively. Individuals experiencing symptoms indicative of scabies should seek medical assistance promptly to prevent further spread of the highly contagious condition. Treatment typically involves permethrin cream, although resistance to this medication has been reported. The NHS has approved Ivermectin as an alternative treatment, emphasizing the importance of thorough cleaning and avoiding close contact to contain the spread of scabies.
